Wang C, Hu Q, Sun Y, Yu F, et al. Complete pathological remission after neoadjuvant ensartinib in patients with locally advanced lung adenocarcinoma and with CTLC-ALK and ALK-DHX8 rearrangements. Eur J Cancer 2022;169:131-134.
PMID: 35567918